| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 9.411 | 14.292 | 15.880 | 14.289 | 13.568 | 17.959 | 23.183 | 28.823 |
| Total Income - EUR | - | - | 9.411 | 14.292 | 15.880 | 14.289 | 13.570 | 17.959 | 23.184 | 28.852 |
| Total Expenses - EUR | - | - | 2.949 | 4.609 | 5.549 | 3.801 | 6.914 | 5.122 | 9.424 | 11.702 |
| Gross Profit/Loss - EUR | - | - | 6.462 | 9.683 | 10.331 | 10.488 | 6.656 | 12.838 | 13.760 | 17.150 |
| Net Profit/Loss - EUR | - | - | 6.180 | 9.262 | 9.856 | 10.093 | 6.400 | 12.507 | 13.533 | 16.388 |
| Employees | - | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Centrul De Excelență Endolife - Dr. Marinova S.r.l
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 14.258 | 25.063 | 24.134 | 25.524 | 15.352 | 15.342 | 15.090 | 14.994 |
| Current Assets | - | - | 3.867 | 6.409 | 3.965 | 12.216 | 18.182 | 23.979 | 8.878 | 6.012 |
| Inventories | - | - | 0 | 89 | 401 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 1.984 | 2.450 | 1.910 | 0 | 0 | 0 | 409 | 0 |
| Cash | - | - | 1.883 | 3.870 | 1.654 | 12.216 | 18.182 | 21.796 | 6.293 | 3.848 |
| Shareholders Funds | - | - | 6.224 | 15.371 | 24.929 | 34.549 | 33.295 | 24.560 | 15.781 | 19.319 |
| Social Capital | - | - | 44 | 43 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debts | - | - | 11.901 | 16.101 | 3.170 | 3.190 | 239 | 14.760 | 8.188 | 1.687 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Centrul De Excelență Endolife - Dr. Marinova S.r.l.